Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) EBT Margin (2016 - 2025)

Ocular Therapeutix (OCUL) has 13 years of EBT Margin data on record, last reported at 492.45% in Q4 2025.

  • For Q4 2025, EBT Margin fell 20555.0% year-over-year to 492.45%; the TTM value through Dec 2025 reached 507.2%, down 24815.0%, while the annual FY2025 figure was 507.2%, 24815.0% down from the prior year.
  • EBT Margin reached 492.45% in Q4 2025 per OCUL's latest filing, down from 467.35% in the prior quarter.
  • Across five years, EBT Margin topped out at 142.09% in Q3 2023 and bottomed at 589.6% in Q1 2025.
  • Average EBT Margin over 5 years is 259.05%, with a median of 189.68% recorded in 2022.
  • Peak YoY movement for EBT Margin: surged 106004bps in 2021, then crashed -37472bps in 2025.
  • A 5-year view of EBT Margin shows it stood at 160.25% in 2021, then rose by 8bps to 147.67% in 2022, then dropped by -4bps to 153.65% in 2023, then tumbled by -87bps to 286.9% in 2024, then tumbled by -72bps to 492.45% in 2025.
  • Per Business Quant database, its latest 3 readings for EBT Margin were 492.45% in Q4 2025, 467.35% in Q3 2025, and 499.31% in Q2 2025.